Significantly Delayed Development of Polyarthritis with Active Tenosynovitis after Possible Temporary Neutropenic Immune-Related Adverse Events Caused by Atezolizumab Treatment: A Novel Case Report
Immune checkpoint inhibitors have drastically improved cancer treatment. However, they may induce immune-related adverse events (irAEs). Here, we report a case of significantly delayed rheumatic irAEs (Rh-irAEs) with prior possible temporary neutropenic irAEs in a patient with atezolizumab-treated n...
Main Authors: | Yoshitaka Saito, Yoh Takekuma, Hajime Asahina, Ryo Hisada, Mitsuru Sugawara |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2024-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2024/1566299 |
Similar Items
-
Temporary Severe Neutropenia during Administration of Atezolizumab: A Novel Case Report
by: Ryota Kanno, et al.
Published: (2023-05-01) -
Impact of preexisting proteinuria on the development of regorafenib-induced problematic proteinuria in real-world metastatic colorectal cancer treatment
by: Yoshitaka Saito, et al.
Published: (2024-03-01) -
Impact of systemic dexamethasone dosage on docetaxel-induced oral mucositis in patients with breast cancer
by: Yoshitaka Saito, et al.
Published: (2023-06-01) -
High dose of dexamethasone attenuates docetaxel-induced fluid retention in breast cancer treatment
by: Yoshitaka Saito, et al.
Published: (2023-06-01) -
Difference in the Dissolution Behaviors of Tablets Containing Polyvinylpolypyrrolidone (PVPP) Depending on Pharmaceutical Formulation After Storage Under High Temperature and Humid Conditions
by: Yoh Takekuma, et al.
Published: (2016-12-01)